Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

AZD-1480, a novel JAK2 inhibitor profiled at AstraZeneca

April 7, 2008

EMEA accepts for review Cell Therapeutics' MAA for Xyotax in NSCLC

April 4, 2008

Carfilzomib receives FDA orphan drug designation in multiple myeloma

April 4, 2008

PharmaMar's Yondelis granted orphan drug status in Switzerland, EMEA approval for phase III trial

April 4, 2008

Follow-up data support effect of green tea catechins in preventing prostate cancer

April 4, 2008

Supratek's SP-1049C granted orphan drug designation for gastric cancer

April 3, 2008

Cougar reaches agreement with FDA under SPA for phase III clinical trial of CB-7630

April 3, 2008

DSMB supports continuation of Genta's phase III AGENDA trial of Genasense in melanoma

April 2, 2008

Acusphere licenses hydrophobic drug delivery system and AI-850 to Cephalon

April 2, 2008

NeoPharm enrolls first patients in phase II cancer trial of liposomal paclitaxel

April 1, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...